EGFR and serous adenocarcinoma: In contrast, other reports showed an association of EGFR expression with higher patient age, larger residual tumor size [5], and high-grade serous carcinomas [5,22], while de Graeff et al. found that over-expression of EGFR was more frequent in non-serous tumors [21].